08/01/2024
3:43 PM | Vir Biotechnology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/16/2024
3:40 PM | Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
2:26 PM | SHARP PHILLIP A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
7:15 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2024
11:21 AM | Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
4:01 PM | PEREZ ROBERT J (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
5:04 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
06/03/2024
11:15 AM | Ramasastry Saira (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:16 AM | SATO VICKI L (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:17 AM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:18 AM | Sigal Charles Elliott (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
10:57 AM | Eisner Mark (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/03/2024
10:59 AM | Hatfield Jeffrey S. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:08 AM | MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:13 AM | Napolitano Janet (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
11:14 AM | NELSEN ROBERT (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
1:38 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
1:40 PM | BISCHOFBERGER NORBERT W (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
1:42 PM | Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/31/2024
1:43 PM | Farid Ramy (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:06 PM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
3:05 PM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/19/2024
7:40 AM | Vir Biotechnology (Filer)
| Form ARS | |
04/19/2024
7:32 AM | Vir Biotechnology (Filer)
| Form DEF 14A | |
04/19/2024
7:35 AM | Vir Biotechnology (Filer)
| Form DEFA14A | |
04/18/2024
7:44 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
3:14 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
7:58 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
11:18 AM | Lee Sung (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:32 PM | Lee Sung (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:32 PM | De Backer Marianne (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:34 PM | HANLY ANN M. (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:30 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
6:31 PM | Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
3:32 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
8:02 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
3:35 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/16/2024
5:56 PM | Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
6:59 AM | STATE STREET CORP (Filed by)
Vir Biotechnology (Subject)
| Form SC 13G | |
01/23/2024
3:14 PM | BlackRock Inc. (Filed by)
Vir Biotechnology (Subject)
| Form SC 13G/A | |
01/03/2024
1:47 PM | Pang Phillip (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
China Stockpiling Gold “Like No Tomorrow” (Ad) For 18 consecutive months, China’s central bank has increased its gold reserve.
The country, with a population of over 1.4 BILLION is “buying gold like there’s no tomorrow,” according to The New York Times.
China, a rising global economic threat, aims to reduce its dependence on the US dollar…
.
 Click here now to get your free 'De-Dollarization' Guide. |
11/03/2023
3:33 PM | Vir Biotechnology (Filer)
| Form S-3ASR | |
11/03/2023
3:37 PM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
1:15 PM | MORE ROBERT J (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
1:14 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
7:01 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2023
5:02 AM | Vir Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
2:54 PM | SCANGOS GEORGE A (Reporting)
Vir Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
